» Articles » PMID: 27040255

Bone Regeneration Using Injectable BMP-7 Loaded Chitosan Microparticles in Rat Femoral Defect

Overview
Publisher Elsevier
Date 2016 Apr 5
PMID 27040255
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Injectable chitosan microparticles were prepared using a simple coacervation method under physiologically friendly conditions by eliminating oil or toxic chemical, and employing low temperature and pressure for growth factor stability. Amount of 200 ng of bone morphogenetic protein-7 (BMP-7) was incorporated in the chitosan microparticles by two methods: encapsulating and coating techniques. These microparticles were tested in vivo to determine the biological response in a rat femoral bone defect at 6 and 12 weeks. Four groups (n=10) were tested which include two groups for BMP-7 incorporated microparticles (by two techniques), microparticles without BMP-7, and defect itself (negative control). Healthy bone formation was observed around the microparticles, which were only confined to the defect site and did not disperse. Histology indicated minor inflammatory response around the microparticles at 6 weeks, which reduced by 12 weeks. Micro-CT analysis of bone surface density and porosity was found to be significantly more (p<0.05) for microparticles containing groups, in comparison with controls, which suggests that the new bone formed in the presence of microparticles is more interconnected and porous. Collagen fibrils analysis conducted using multiphoton microscopy showed significant improvement in the formation of bundled collagen area (%) in microparticles containing groups in comparison with controls, indicating higher cross-linking between the fibrils. Microparticles were biocompatible and did not degrade in the 12 week implant period.

Citing Articles

Tissue Engineering and Regenerative Medicine in the Field of Otorhinolaryngology.

Oh S, Kim H, Jung S, Kim H Tissue Eng Regen Med. 2024; 21(7):969-984.

PMID: 39017827 PMC: 11416456. DOI: 10.1007/s13770-024-00661-1.


Bone Morphogenetic Protein 7-Loaded Gelatin Methacrylate/Oxidized Sodium Alginate/Nano-Hydroxyapatite Composite Hydrogel for Bone Tissue Engineering.

Huang S, Wang Z, Sun X, Li K Int J Nanomedicine. 2024; 19:6359-6376.

PMID: 38946885 PMC: 11214552. DOI: 10.2147/IJN.S461996.


Surface-modified titanium and titanium-based alloys for improved osteogenesis: A critical review.

Li J, Zheng Y, Yu Z, Kankala R, Lin Q, Shi J Heliyon. 2024; 10(1):e23779.

PMID: 38223705 PMC: 10784177. DOI: 10.1016/j.heliyon.2023.e23779.


Development of triple-functionalized calcium phosphate nanoparticles as an advanced drug delivery system for bone tissue repair.

Tenkumo T, Kruse B, Kostka K, Sokolova V, Ogawa T, Yoda N Regen Ther. 2023; 25:49-60.

PMID: 38089138 PMC: 10711038. DOI: 10.1016/j.reth.2023.11.010.


Alginate/Gelatin Hydrogel Scaffold Containing nCeO as a Potential Osteogenic Nanomaterial for Bone Tissue Engineering.

Li F, Li J, Song X, Sun T, Mi L, Liu J Int J Nanomedicine. 2022; 17:6561-6578.

PMID: 36578441 PMC: 9791564. DOI: 10.2147/IJN.S388942.


References
1.
Shin H, Ruhe P, Mikos A, Jansen J . In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials. 2003; 24(19):3201-11. DOI: 10.1016/s0142-9612(03)00168-6. View

2.
Stamov D, Muller A, Wegrowski Y, Brezillon S, Franz C . Quantitative analysis of type I collagen fibril regulation by lumican and decorin using AFM. J Struct Biol. 2013; 183(3):394-403. DOI: 10.1016/j.jsb.2013.05.022. View

3.
Aryaei A, Jayatissa A, Jayasuriya A . Mechanical and biological properties of chitosan/carbon nanotube nanocomposite films. J Biomed Mater Res A. 2013; 102(8):2704-12. PMC: 4443444. DOI: 10.1002/jbm.a.34942. View

4.
Zioupos P . Accumulation of in-vivo fatigue microdamage and its relation to biomechanical properties in ageing human cortical bone. J Microsc. 2001; 201(2):270-278. View

5.
Mantripragada V, Jayasuriya A . IGF-1 release kinetics from chitosan microparticles fabricated using environmentally benign conditions. Mater Sci Eng C Mater Biol Appl. 2014; 42:506-16. PMC: 4112056. DOI: 10.1016/j.msec.2014.05.068. View